Stories on US FDA approving injectable Roche multiple sclerosis therapy are withdrawn

FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

(Reuters) - Stories on Roche receiving FDA approval for an injectable version of its multiple sclerosis therapy are incorrect and are withdrawn. There will be no replacement story.

(Reporting by Sneha S K,Sruthi Narasimha Chari and Urvi Dugar in Bengaluru; Editing by Shilpi Majumdar and Subhranshu Sahu)